Wang Tony C DDS in Los Angeles, California
-
Aurora Sheboygan Prices – AMINOLEVULINIC ACID HCL 1.5 G PO SOLR is $12,044.15
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding AMINOLEVULINIC ACID HCL 1.5 G PO SOLR, which is classified under revenue code 250 and associated with CPT code C9399, the designated fee stands at $12,044.15. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – POC URINE DIPSTICK W/O MICRO is $35
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10000747, regarding POC URINE DIPSTICK W/O MICRO, which is classified under revenue code 300 and associated with CPT code 81002, the designated fee stands at $35. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Chronic Pain and Mental Health in Phoenix, Arizona: Treatments at Local Clinics
Chronic Pain and Mental Health in Phoenix, Arizona: Treatments at Local Clinics examines how Phoenix clinics address the intertwined challenges of chronic pain and mental well-being. The article describes integrated, multidisciplinary care in which pain specialists work with mental health professionals, physical and occupational therapists, and other clinicians to develop personalized treatment plans. It highlights evidence-based options ranging from medications and injections to nonpharmacological therapies like physical therapy, cognitive-behavioral therapy, mindfulness, and sleep hygiene, all aimed at reducing pain and improving mood and functioning. It also covers practical considerations for patients and caregivers, including how to evaluate local clinics, what questions to ask, and how to navigate insurance and access to ongoing support. The key value for readers is a reliable, locally focused resource that helps patients, families, or anyone seeking trustworthy health information understand available treatments and make informed decisions to improve quality of life.
-
FDA proposes withdrawing Tavneos after liver-injury warnings
The FDA has proposed withdrawing approval of Tavneos, a drug used with standard treatment for some adults with ANCA-associated vasculitis. The agency says the proposal is not a final removal, and the medicine remains available while the process continues.